Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Analysis of airway pathology in COPD using a combination of computed tomography, micro-computed tomography and histology.

Tanabe N, Vasilescu DM, Kirby M, Coxson HO, Verleden SE, Vanaudenaerde BM, Kinose D, Nakano Y, Paré PD, Hogg JC.

Eur Respir J. 2018 Feb 14;51(2). pii: 1701245. doi: 10.1183/13993003.01245-2017. Print 2018 Feb.

PMID:
29444912
2.

Aspergillus fumigatus Detection and Risk Factors in Patients with COPD-Bronchiectasis Overlap.

Everaerts S, Lagrou K, Vermeersch K, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Mol Sci. 2018 Feb 9;19(2). pii: E523. doi: 10.3390/ijms19020523.

3.

Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation.

Verleden SE, Martens A, Ordies S, Neyrinck AP, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.

Clin Transplant. 2018 Feb 6. doi: 10.1111/ctr.13219. [Epub ahead of print]

PMID:
29405435
4.

Epithelial grafting of a decellularized whole-tracheal segment: an in vivo experimental model.

Den Hondt M, Vanaudenaerde BM, Verbeken EK, Vranckx JJ.

Interact Cardiovasc Thorac Surg. 2018 Jan 15. doi: 10.1093/icvts/ivx442. [Epub ahead of print]

PMID:
29346567
5.

Prevention of chronic rejection after lung transplantation.

Van Herck A, Verleden SE, Vanaudenaerde BM, Verleden GM, Vos R.

J Thorac Dis. 2017 Dec;9(12):5472-5488. doi: 10.21037/jtd.2017.11.85. Review.

6.

Association of innate defense proteins BPIFA1 and BPIFB1 with disease severity in COPD.

De Smet EG, Seys LJ, Verhamme FM, Vanaudenaerde BM, Brusselle GG, Bingle CD, Bracke KR.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 19;13:11-27. doi: 10.2147/COPD.S144136. eCollection 2018.

7.

Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.

Verleden SE, Vanaudenaerde BM, Emonds MP, Van Raemdonck DE, Neyrinck AP, Verleden GM, Vos R.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701248. doi: 10.1183/13993003.01248-2017. Print 2017 Nov.

PMID:
29146602
8.

Chronic lung allograft dysfunction phenotypes and treatment.

Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM.

J Thorac Dis. 2017 Aug;9(8):2650-2659. doi: 10.21037/jtd.2017.07.81. Review.

9.

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD.

Everaerts S, Lagrou K, Dubbeldam A, Lorent N, Vermeersch K, Van Hoeyveld E, Bossuyt X, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 31;12:2629-2638. doi: 10.2147/COPD.S141695. eCollection 2017.

10.

Solid Organ Transplantation in Sarcoidosis.

Yserbyt J, Wuyts WA, Verleden SE, Verleden GM, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Vos R.

Semin Respir Crit Care Med. 2017 Aug;38(4):538-545. doi: 10.1055/s-0037-1602383. Epub 2017 Jul 27. No abstract available.

PMID:
28750467
11.

An optimized non-destructive protocol for testing mechanical properties in decellularized rabbit trachea.

Den Hondt M, Vanaudenaerde BM, Maughan EF, Butler CR, Crowley C, Verbeken EK, Verleden SE, Vranckx JJ.

Acta Biomater. 2017 Sep 15;60:291-301. doi: 10.1016/j.actbio.2017.07.035. Epub 2017 Jul 21.

PMID:
28739545
12.

Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Van Raemdonck DE, Verleden GM, Roobrouck VD, Claes S, Schols D, Verbeken E, Verfaillie CM, Neyrinck AP.

Stem Cell Res Ther. 2017 Jul 5;8(1):159. doi: 10.1186/s13287-017-0603-5.

13.

A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors.

Martens A, Van Raemdonck DE, Smits J, Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM, Degezelle K, Desschans B, Neyrinck AP.

Transpl Int. 2017 Oct;30(10):1002-1010. doi: 10.1111/tri.12990. Epub 2017 Jul 13.

PMID:
28556538
14.

A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck DE, Claes S, Schols D, Chalopin M, Katz I, Farjot G, Neyrinck AP.

Med Gas Res. 2017 Mar 30;7(1):28-36. doi: 10.4103/2045-9912.202907. eCollection 2017 Jan-Mar.

15.

The Effect of Immunosuppression on Airway Integrity.

Bellon H, Vandermeulen E, Verleden SE, Heigl T, Vriens H, Lammertyn E, Verlinden L, Vanhove T, Verstuyf M, Hoet P, Vos R, Verleden GM, Vanaudenaerde BM.

Transplantation. 2017 Dec;101(12):2855-2861. doi: 10.1097/TP.0000000000001809.

PMID:
28471870
16.

Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.

Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12983. Epub 2017 May 8.

PMID:
28383790
17.

High-dose vitamin D after lung transplantation: A randomized trial.

Vos R, Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Van Herck A, Sacreas A, Heigl T, Schaevers V, Van Raemdonck DE, Verbeken EK, Neyrinck AP, Dupont LJ, Yserbyt J, Vanaudenaerde BM, Verleden GM.

J Heart Lung Transplant. 2017 Aug;36(8):897-905. doi: 10.1016/j.healun.2017.03.008. Epub 2017 Mar 8.

PMID:
28365177
18.

Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors: A Single-Center Experience.

Ruttens D, Martens A, Ordies S, Verleden SE, Neyrinck AP, Vos R, Boada MC, Vanaudenaerde BM, Verleden GM, Van Raemdonck D.

Transplantation. 2017 Nov;101(11):2691-2694. doi: 10.1097/TP.0000000000001678.

PMID:
28207629
19.

Interleukin-1α induced release of interleukin-8 by human bronchial epithelial cells in vitro: assessing mechanisms and possible treatment options.

Bellon H, Vandermeulen E, Mathyssen C, Sacreas A, Verleden SE, Heigl T, Vriens H, Lammertyn E, Pilette C, Hoet P, Vos R, Vanaudenaerde BM, Verleden GM.

Transpl Int. 2017 Apr;30(4):388-397. doi: 10.1111/tri.12915. Epub 2017 Mar 2.

PMID:
28078769
20.

End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis.

Lammertyn EJ, Vandermeulen E, Bellon H, Everaerts S, Verleden SE, Van Den Eynde K, Bracke KR, Brusselle GG, Goeminne PC, Verbeken EK, Vanaudenaerde BM, Dupont LJ.

Respir Res. 2017 Jan 10;18(1):10. doi: 10.1186/s12931-016-0489-2.

21.

Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis.

Vandermeulen E, Lammertyn E, Verleden SE, Ruttens D, Bellon H, Ricciardi M, Somers J, Bracke KR, Van Den Eynde K, Tousseyn T, Brusselle GG, Verbeken EK, Verschakelen J, Emonds MP, Van Raemdonck DE, Verleden GM, Vos R, Vanaudenaerde BM.

Transpl Int. 2017 Feb;30(2):134-143. doi: 10.1111/tri.12882. Epub 2016 Dec 8.

22.

Nondestructive cryomicro-CT imaging enables structural and molecular analysis of human lung tissue.

Vasilescu DM, Phillion AB, Tanabe N, Kinose D, Paige DF, Kantrowitz JJ, Liu G, Liu H, Fishbane N, Verleden SE, Vanaudenaerde BM, Lenburg M, Stevenson CS, Spira A, Cooper JD, Hackett TL, Hogg JC.

J Appl Physiol (1985). 2017 Jan 1;122(1):161-169. doi: 10.1152/japplphysiol.00838.2016. Epub 2016 Nov 17.

PMID:
27856720
23.

An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe.

Ruttens D, Verleden SE, Bijnens EM, Winckelmans E, Gottlieb J, Warnecke G, Meloni F, Morosini M, Van Der Bij W, Verschuuren EA, Sommerwerck U, Weinreich G, Kamler M, Roman A, Gomez-Olles S, Berastegui C, Benden C, Holm AM, Iversen M, Schultz HH, Luijk B, Oudijk EJ, Kwakkel-van Erp JM, Jaksch P, Klepetko W, Kneidinger N, Neurohr C, Corris P, Fisher AJ, Lordan J, Meachery G, Piloni D, Vandermeulen E, Bellon H, Hoffmann B, Vienneau D, Hoek G, de Hoogh K, Nemery B, Verleden GM, Vos R, Nawrot TS, Vanaudenaerde BM.

Eur Respir J. 2017 Jan 18;49(1). pii: 1600484. doi: 10.1183/13993003.00484-2016. Print 2017 Jan.

PMID:
27836956
24.

Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation.

Martens A, Boada M, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck D, Schols D, Claes S, Neyrinck AP.

Transpl Int. 2016 Nov;29(11):1237-1246. doi: 10.1111/tri.12823.

25.

Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.

Verleden SE, Vos R, Vandermeulen E, Ruttens D, Bellon H, Heigl T, Van Raemdonck DE, Verleden GM, Lama V, Ross BD, Galbán CJ, Vanaudenaerde BM.

Am J Transplant. 2016 Nov;16(11):3262-3269. doi: 10.1111/ajt.13945. Epub 2016 Jul 29.

26.

Phenotypes of Chronic Lung Allograft Dysfunction: Getting Closer Step by Step?

Verleden SE, Vanaudenaerde BM, Vos R, Verleden GM.

Am J Transplant. 2016 Nov;16(11):3071-3072. doi: 10.1111/ajt.13921. Epub 2016 Jul 13. No abstract available.

27.

The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.

Yamada Y, Vandermeulen E, Heigl T, Somers J, Vaneylen A, Verleden SE, Bellon H, De Vleeschauwer S, Verbeken EK, Van Raemdonck DE, Vos R, Verleden GM, Jungraithmayr W, Vanaudenaerde BM.

Transpl Immunol. 2016 Nov;39:10-17. doi: 10.1016/j.trim.2016.10.001. Epub 2016 Oct 11.

PMID:
27737799
28.

Thin-Section CT Features of Idiopathic Pulmonary Fibrosis Correlated with Micro-CT and Histologic Analysis.

Mai C, Verleden SE, McDonough JE, Willems S, De Wever W, Coolen J, Dubbeldam A, Van Raemdonck DE, Verbeken EK, Verleden GM, Hogg JC, Vanaudenaerde BM, Wuyts WA, Verschakelen JA.

Radiology. 2017 Apr;283(1):252-263. doi: 10.1148/radiol.2016152362. Epub 2016 Oct 6.

PMID:
27715655
29.

Tracheal tissue-engineering: in-vivo biocompatibility of mechanically-stripped allogenic rabbit trachea with autologous epithelial covering.

Den Hondt M, Vanaudenaerde BM, Verbeken EK, Vranckx JJ.

Acta Chir Belg. 2016 Oct 4:1-11. [Epub ahead of print]

PMID:
27696973
30.

Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.

Vandermeulen E, Verleden SE, Bellon H, Ruttens D, Lammertyn E, Claes S, Vandooren J, Ugarte-Berzal E, Schols D, Emonds MP, Van Raemdonck DE, Opdenakker G, Verleden GM, Vos R, Vanaudenaerde BM.

Transpl Immunol. 2016 Sep;38:27-32. doi: 10.1016/j.trim.2016.08.004. Epub 2016 Aug 22.

PMID:
27561239
31.

MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Conickx G, Mestdagh P, Avila Cobos F, Verhamme FM, Maes T, Vanaudenaerde BM, Seys LJ, Lahousse L, Kim RY, Hsu AC, Wark PA, Hansbro PM, Joos GF, Vandesompele J, Bracke KR, Brusselle GG.

Am J Respir Crit Care Med. 2017 Jan 1;195(1):43-56. doi: 10.1164/rccm.201506-1182OC.

PMID:
27409149
32.

Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.

Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Dubbeldam A, De Wever W, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM, Verleden GM, Benden C, Vos R.

J Heart Lung Transplant. 2016 Sep;35(9):1078-84. doi: 10.1016/j.healun.2016.03.022. Epub 2016 Apr 16.

PMID:
27212563
33.

Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation.

Verleden SE, Sacreas A, Vos R, Vanaudenaerde BM, Verleden GM.

Chest. 2016 Jul;150(1):219-25. doi: 10.1016/j.chest.2016.04.014. Epub 2016 May 20. Review.

PMID:
27212132
34.

Argon and xenon ventilation during prolonged ex vivo lung perfusion.

Martens A, Montoli M, Faggi G, Katz I, Pype J, Vanaudenaerde BM, Van Raemdonck DE, Neyrinck AP.

J Surg Res. 2016 Mar;201(1):44-52. doi: 10.1016/j.jss.2015.10.007. Epub 2015 Oct 12.

PMID:
26850183
35.

Morphometric Analysis of Explant Lungs in Cystic Fibrosis.

Boon M, Verleden SE, Bosch B, Lammertyn EJ, McDonough JE, Mai C, Verschakelen J, Kemner-van de Corput M, Tiddens HA, Proesmans M, Vermeulen FL, Verbeken EK, Cooper J, Van Raemdonck DE, Decramer M, Verleden GM, Hogg JC, Dupont LJ, Vanaudenaerde BM, De Boeck K.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):516-26. doi: 10.1164/rccm.201507-1281OC.

PMID:
26551917
36.

CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.

Vercauteren IM, Verleden SE, McDonough JE, Vandermeulen E, Ruttens D, Lammertyn EJ, Bellon H, De Dycker E, Dooms C, Yserbyt J, Verleden GM, Vanaudenaerde BM, Wuyts WA.

Exp Lung Res. 2015;41(8):459-65. doi: 10.3109/01902148.2015.1073407.

PMID:
26381718
37.

Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.

Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Vanaudenaerde BM, Somers J, Schoonis A, Schaevers V, Van Raemdonck DE, Neyrinck A, Dupont LJ, Yserbyt J, Verleden GM, Vos R.

Am J Transplant. 2016 Jan;16(1):254-61. doi: 10.1111/ajt.13417. Epub 2015 Aug 4.

38.

BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance.

Vandermeulen E, Verleden SE, Ruttens D, Moelants E, Mortier A, Somers J, Bellon H, Piloni D, Dupont LJ, Van Raemdonck DE, Proost P, Schols D, Vos R, Verleden GM, Vanaudenaerde BM.

Transpl Immunol. 2015 Sep;33(1):37-44. doi: 10.1016/j.trim.2015.07.001. Epub 2015 Jul 11.

PMID:
26168736
39.

Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure.

Verleden SE, Vasilescu DM, McDonough JE, Ruttens D, Vos R, Vandermeulen E, Bellon H, Geenens R, Verbeken EK, Verschakelen J, Van Raemdonck DE, Wuyts WA, Sokolow Y, Knoop C, Cooper JD, Hogg JC, Verleden GM, Vanaudenaerde BM.

Eur Respir J. 2015 Nov;46(5):1430-9. doi: 10.1183/09031936.00010615. Epub 2015 Jun 25.

40.

Role of genetics in lung transplant complications.

Ruttens D, Vandermeulen E, Verleden SE, Bellon H, Vos R, Van Raemdonck DE, Dupont LJ, Vanaudenaerde BM, Verleden GM.

Ann Med. 2015 Mar;47(2):106-15. doi: 10.3109/07853890.2015.1004359. Epub 2015 Mar 13. Review.

PMID:
25766881
41.

Restrictive chronic lung allograft dysfunction: Where are we now?

Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Van Raemdonck DE, Dupont LJ, Vanaudenaerde BM, Verleden G, Vos R.

J Heart Lung Transplant. 2015 May;34(5):625-30. doi: 10.1016/j.healun.2014.11.007. Epub 2014 Nov 11.

PMID:
25577564
42.

Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation.

Vos R, Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Neyrinck A, Van Raemdonck DE, Yserbyt J, Dupont LJ, Verbeken EK, Moelants E, Mortier A, Proost P, Schols D, Cox B, Verleden GM, Vanaudenaerde BM.

Am J Transplant. 2014 Dec;14(12):2736-48. doi: 10.1111/ajt.12942. Epub 2014 Nov 13.

43.

A decade of extended-criteria lung donors in a single center: was it justified?

Somers J, Ruttens D, Verleden SE, Cox B, Stanzi A, Vandermeulen E, Vos R, Vanaudenaerde BM, Verleden GM, Van Veer H, Coosemans W, Decaluwe H, Nafteux P, De Leyn P, Van Raemdonck DE.

Transpl Int. 2015 Feb;28(2):170-9. doi: 10.1111/tri.12470. Epub 2014 Oct 30.

44.

Pregnancy after heart and lung transplantation.

Vos R, Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Vanaudenaerde BM, Verleden GM.

Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1146-62. doi: 10.1016/j.bpobgyn.2014.07.019. Epub 2014 Aug 6.

PMID:
25179291
45.

Are we near to an effective drug treatment for bronchiolitis obliterans?

Verleden GM, Vos R, Dupont L, Van Raemdonck DE, Vanaudenaerde BM, Verleden SE.

Expert Opin Pharmacother. 2014 Oct;15(15):2117-20. doi: 10.1517/14656566.2014.954549. Epub 2014 Aug 25.

PMID:
25154562
46.

Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.

Verleden SE, Ruttens D, Vos R, Vandermeulen E, Moelants E, Mortier A, Van Raemdonck DE, Proost P, Schols D, Verleden GM, Vanaudenaerde BM.

Transplantation. 2015 Jan;99(1):86-93. doi: 10.1097/TP.0000000000000269.

PMID:
25050473
47.

Body mass index in lung transplant candidates: a contra-indication to transplant or not?

Ruttens D, Verleden SE, Vandermeulen E, Vos R, van Raemdonck DE, Vanaudenaerde BM, Verleden GM.

Transplant Proc. 2014 Jun;46(5):1506-10. doi: 10.1016/j.transproceed.2014.04.004.

PMID:
24935321
48.

Genetic variation in immunoglobulin G receptor affects survival after lung transplantation.

Ruttens D, Verleden SE, Goeminne PC, Vandermeulen E, Wauters E, Cox B, Vos R, Van Raemdonck DE, Lambrechts D, Vanaudenaerde BM, Verleden GM.

Am J Transplant. 2014 Jul;14(7):1672-7. doi: 10.1111/ajt.12745. Epub 2014 May 6.

49.

Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.

Suwara MI, Vanaudenaerde BM, Verleden SE, Vos R, Green NJ, Ward C, Borthwick LA, Vandermeulen E, Lordan J, Van Raemdonck DE, Corris PA, Verleden GM, Fisher AJ.

Transpl Int. 2014 Aug;27(8):857-67. doi: 10.1111/tri.12341. Epub 2014 Jun 17.

50.

Genetic variation in caveolin-1 affects survival after lung transplantation.

Vandermeulen E, Ruttens D, Verleden SE, Vos R, Van Raemdonck DE, Kastelijn EA, Wauters E, Lambrechts D, Nawrot TS, Cox B, Verleden GM, Vanaudenaerde BM.

Transplantation. 2014 Aug 15;98(3):354-9. doi: 10.1097/TP.0000000000000058.

PMID:
24621537

Supplemental Content

Loading ...
Support Center